Bio Green Med Solution (BGMS) Net Income (QoQ) (2010 - 2026)
Analysis
Bio Green Med Solution (BGMS) Net Income (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.21 Bn | 133.36 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.88 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 57.17 Bn | 52.03 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.56 Bn | 44.56 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.56 Bn | 32.25 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.24 Bn | 27.40 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.23 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 5.03 Mn | 1.24 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -105.58% |
| Mar 31, 2026 | -4,040.00% |
| Dec 31, 2025 | 100.51% |
| Sep 30, 2025 | 25.04% |
| Jun 30, 2025 | -1,527.16% |
| Mar 31, 2025 | 93.97% |
| Dec 31, 2024 | 31.37% |
| Sep 30, 2024 | 39.91% |
| Jun 30, 2024 | -10.56% |
| Mar 31, 2024 | -1.55% |
| Dec 31, 2023 | 51.91% |
| Sep 30, 2023 | -10.72% |
| Jun 30, 2023 | 6.13% |
| Mar 31, 2023 | 13.30% |
| Dec 31, 2022 | -31.36% |
| Sep 30, 2022 | -11.39% |
| Jun 30, 2022 | -11.37% |
| Mar 31, 2022 | -144.74% |
| Dec 31, 2021 | 238.58% |
| Sep 30, 2021 | -29.22% |